Richard Boleat Acquires 10,000 Shares of M&G Credit Income Investment (LON:MGCI) Stock January 6, 2026 by InsiderTrades.com Share Key Points Richard Boleat purchased 10,000 shares of M&G Credit Income Investment (LON:MGCI) on Jan 1 at an average price of GBX 95 per share for £9,500, after a prior purchase of 10,200 shares on Nov 5 at GBX 94 (£9,588). The stock opened at GBX 95, has a market capitalization of £187.71 million, a price-to-earnings ratio of 16.18, a 12‑month range of GBX 92.80–99.80, and 50-/200-day simple moving averages around GBX 94.6 and 95.2. M&G Credit Income Investment Trust plc invests in a portfolio of public and private debt and debt‑like instruments and is based in London, having been incorporated in 2018. M&G Credit Income Investment (LON:MGCI - Get Free Report) insider Richard Boleat purchased 10,000 shares of the business's stock in a transaction dated Thursday, January 1st. The shares were acquired at an average price of GBX 95 per share, for a total transaction of £9,500. Richard Boleat also recently made the following trade(s): On Wednesday, November 5th, Richard Boleat acquired 10,200 shares of M&G Credit Income Investment stock. The stock was acquired at an average cost of GBX 94 per share, for a total transaction of £9,588. M&G Credit Income Investment Price PerformanceLON MGCI opened at GBX 95 on Tuesday. The company has a market capitalization of £187.71 million, a price-to-earnings ratio of 16.18 and a beta of 0.38. M&G Credit Income Investment has a twelve month low of GBX 92.80 and a twelve month high of GBX 99.80. The stock has a fifty day simple moving average of GBX 94.64 and a 200 day simple moving average of GBX 95.20. About M&G Credit Income Investment (Get Free Report)M&G Credit Income Investment Trust plc invests in a portfolio of public and private debt and debt-like instruments. The company was incorporated in 2018 and is based in London, the United Kingdom. Featured StoriesFive stocks we like better than M&G Credit Income InvestmentA month before the crashHow a Family Trust May Be Able To Help Preserve Your WealthBNZI: BNZI Surges Ahead as AI Marketing Fuels Record RevenueA U.S. “birthright” claim worth trillions - activated quietlyA Message From An Ex-CIA Officer About TrumpThis instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected]. Insider Buying or Selling at M&G Credit Income Investment? Sign-up to receive InsiderTrades.com's daily insider buying and selling report for M&G Credit Income Investment and related companies. From Our PartnersYDES Could Be 2026's Biotech BreakthroughSome emerging healthcare companies are moving beyond early-stage research and beginning to generate commercial...Smallcaps Daily | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredTrump’s new AI budget just passed — one stock could soarIn a quiet move few people noticed... President Trump just green-lit what could become the biggest AI budge...Behind the Markets | Sponsored33,000% boom from weird new “AI Fuel?”The American dream is coming alive again in our Heartland thanks to a strange new technology… Jeff Brown sa...Brownstone Research | SponsoredOnce-in-a-generation financial crisis is comingAn unstoppable force is reshaping America — one so powerful it’s already disrupting how we work, invest, and l...Porter & Company | SponsoredThe “King of Technicals” Just Issued His Most Important Call Yet”JC Parets — widely followed for his technical research and known for calling major turning points in 2008, 202...Trend Labs | SponsoredHit Your Retirement “Freedom Number” (Without $1 Million)Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredBuy this stock tomorrow?Not a Single "Mag 7" on This Legendary Investors List A renowned former hedge fund manager – friends to som...Stansberry Research | Sponsored Free Insider Buying and Selling Newsletter Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report. From Our PartnersYDES Could Be 2026's Biotech BreakthroughSome emerging healthcare companies are moving beyond early-stage research and beginning to generate commercial...Smallcaps Daily | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredTrump’s new AI budget just passed — one stock could soarIn a quiet move few people noticed... President Trump just green-lit what could become the biggest AI budge...Behind the Markets | Sponsored33,000% boom from weird new “AI Fuel?”The American dream is coming alive again in our Heartland thanks to a strange new technology… Jeff Brown sa...Brownstone Research | SponsoredOnce-in-a-generation financial crisis is comingAn unstoppable force is reshaping America — one so powerful it’s already disrupting how we work, invest, and l...Porter & Company | Sponsored Most Read This MonthInsiders Buy Natural Gas Stocks: 2 for the WatchlistPaychex Is Out of Favor—And That’s the OpportunityInsiders Made Their Bets in 2025—These Were the Top 5 Stocks They BoughtThe AI Tech Paradox: Insiders Sell, the Case for Buying Gets StrongerMaplebear (NASDAQ:CART) General Counsel Morgan Fong Sells 4,914 SharesIncyte (NASDAQ:INCY) EVP Michael James Morrissey Sells 54,008 SharesInsider Selling: Rocket Lab (NASDAQ:RKLB) Director Sells 5,000 Shares of StockOkta (NASDAQ:OKTA) Insider Eric Robert Kelleher Sells 127 SharesRecent ArticlesAcumen Pharmaceuticals (NASDAQ:ABOS) CFO Matt Zuga Sells 5,100 SharesCamden Property Trust (NYSE:CPT) Director Javier Benito Sells 101 SharesDelek Logistics Partners (NYSE:DKL) EVP Reuven Spiegel Sells 250 SharesWerewolf Therapeutics (NASDAQ:HOWL) Director Sells $11,761.92 in StockInsider Buying: Nuvilex (NASDAQ:PMCB) Director Acquires 20,000 Shares of StockInsider Selling: Travere Therapeutics (NASDAQ:TVTX) Insider Sells $16,798.75 in StockAiRWA (NASDAQ:YYAI) Director Hongyu Zhou Purchases 16,830 SharesClene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 3,111 Shares